Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04548674
Other study ID # UFPara-008
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date August 20, 2018
Est. completion date June 30, 2019

Study information

Verified date September 2020
Source Universidade Federal do Para
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This randomized, controlled, blinded clinical trial evaluated the effectiveness of different desensitizing protocols in preventing pulp inflammation after bleaching treatment with 35% hydrogen peroxide (PH) (Whiteness PH 35%).


Description:

Thirty healthy third human molars extracted by orthodontic indication were randomized and allocated into five groups (n = 6): CN (negative control): without intervention; CP (Positive control): PH; PMB: PH + photobiomodulation with low power laser; CPP: PH + casein phosphopeptide phosphopeptide amorphous calcium phosphate (CPP-ACPF); NANO: PH + nanohydroxyapatite. The office whitening was performed in two sessions with a single application of 45 min and an interval of 48 hours between them. Pulp tissues were removed for immunohistochemical analysis. Immunostaining was performed for Caspase 3 using an Axio Scope.A1 microscope.


Recruitment information / eligibility

Status Completed
Enrollment 18
Est. completion date June 30, 2019
Est. primary completion date March 15, 2019
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 20 Years to 26 Years
Eligibility Inclusion criteria:

- Lower third molars class I position A

- Maxillary third molars horizontal position A

- Absence of caries and enamel fracture

- Absence of periodontal disease

- Extraction of third molars for orthodontic reasons

- No allergy to the anesthetic and positive pulp sensitivity test

Exclusion criteria:

- Calcification in the middle third of the root

- Drug users or smokers

- Patients who have already done whitening

- Root apex with incomplete formation and patients with systemic problems that would make surgery impossible

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Whiteness HP 35%
Single application of 45 minutes on the buccal surfaces of third molars, with an average thickness of 1 mm
Device:
Whiteness HP 35% + LASER
A dose of LASER (60 J / cm2, for 16 seconds) was applied at two points, one point in the cervical region and another in the center of the buccal surface of the third molars, using visible infrared LASER therapy (Photon III / DMC, São Carlos, SP, Brazil), with a wavelength of 808 nm, and AsGaAl, as an active medium.
Other:
Whiteness HP 35% + CPP
Topical application of casein phosphopeptide amorphous calcium phosphate fluoride CPP-ACPF (My Paste Plus, Recaldent, GC, USA) with the aid of a microbrush (KG Sorensen, SP, Brazil) in a passive way for 5 minutes.
Whiteness HP 35% + NANO
A topical application of nanohydroxyapatite (Nano P FGM, SC, Brazil) was performed with the aid of a microbrush (KG Sorensen, SP, Brazil) in a passive way for 5 minutes after teeth whitening.

Locations

Country Name City State
Brazil Universidade Federal do Pará Belém Pará

Sponsors (1)

Lead Sponsor Collaborator
Universidade Federal do Para

Country where clinical trial is conducted

Brazil, 

Outcome

Type Measure Description Time frame Safety issue
Primary Pulp inflammation Evaluation of pulp inflammation through immunohistochemistry of the third molar whitening or not 3 days After extraction of third molars